The occurrence of ovarian cancer in the population of urban and rural women, BRCA1 and BRCA2 genes mutation testing and the general rules on the patient’s consent to treatment

Maria Połocka-Molińska; Katarzyna Plagens-Rotman; Wojciech Trusz; Matylda Gwoździcka-Piotrowska; Grażyna Jarząbek-Bielecka; Anna Molińska-Kulesza; Witold Kędzia

doi:10.2478/pielxxiw-2021-0016

References

1. Didkowska J, Wojciechowska U, Czaderny K. Nowotwory złośliwe w Polsce w 2017 roku. Krajowy Rejestr Nowotworów. Warszawa: Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie, 2019.
Search in Google Scholar Back to article
2. Plagens-Rotman K, Chmaj-Wierzchowska K, Pięta B, Bojar I. Modifiable lifestyle factors and ovarian cancer incidence in women. Ann. Agric. Environ. Med. 2018; 1: 36-40.
Search in Google Scholar Back to article
3. Kurman RJ, Shih IM. The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory. Am. J. Surg. Pathol. 2010; 34: 433-443.
Search in Google Scholar Back to article
4. Budiana ING, Angelina M, Pemayun TGA. Varian cancer: Pathogenesis and current recommendations for prophylactic surgery. J. Turk. Ger. Gynecol. Assoc. 2019; 26: 47-54.
Search in Google Scholar Back to article
5. Mavaddat N, Peock S, Frost D. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of embrace. J. Natl. Cancer. Inst. 2013; 5: 812-822.
Search in Google Scholar Back to article
6. Dowdy SC, Stefanek M, Hartmann LC. Surgical risk reduction: prophylactic salpingooophorectomy and prophylactic mastectomy. Am. J. Obstet. Gynecol. 2004; 191: 1113-1123.
Search in Google Scholar Back to article
7. Koh SC, Huak CY, Lutan D, et al. Combined panel of serum human tissue kallikreins and CA-125 for the detection of epithelial ovarian cancer. J. Gynecol. Oncol. 2012; 23: 175-181.
Search in Google Scholar Back to article
8. Kossai M, Leary A, Scoazec J-Y, Genestie C. Ovarian Cancer; A heterogeneous disease. Pathobiology. 2018; 85(1-2): 41-49.
Search in Google Scholar Back to article
9. Xinxin Z, Jinghe L. Programmed death-1Pathway Blockade Produces a Synergistic Antitumor Effect Combined Application In Ovarian Cancer. J. Gynecol. Oncol. 2017; 5: 64.
Search in Google Scholar Back to article
10. Eisenhauer EA. Real-world evidence. In the treatment of ovaria cancer. Ann. Oncol. 2011; 1(8): 28.
Search in Google Scholar Back to article
11. Vargas AN. Natural history of ovarian cancer. J. Cancer. Sci. Ther. 2014; 6: 247-252.
Search in Google Scholar Back to article
12. Lalrinpuii E, Bhageerathy PS, Sebastian A. Ovarian Cancer in Young Women. Peedicayil. A Indian. J. Surg. Oncol. 2017; 4: 540-547.
Search in Google Scholar Back to article
13. Pujade-Lauraine E, Ledermann JA, Selle F, et al. Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Oncol. 2017; 9: 1274-1284.
Search in Google Scholar Back to article
14. Kruczała MA, Grela-Wojewoda A, Cedrych I. PARP inhibitors in the ovarian cancer therapy. Ginekol. Pol. 2016; 87: 131-134.
Search in Google Scholar Back to article
15. Górski B, Byrski T, Huzarski T, et.al. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am. J. Hum. Genet. 2000; 6: 1963-1968.
Search in Google Scholar Back to article
16. Riedlova P, Janoutova J, Hermanova B. Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic. Mol. Biol. Rep. 2020; 4: 2763-2769.
Search in Google Scholar Back to article
17. Plagens-Rotman K, Chuchracki M, Piskorz-Szymendera M, et al. Reproductive factors and the endometrial cancer morbidity. Eur. J. Gynaecol. Oncol. 2019; 3: 431-436.
Search in Google Scholar Back to article
18. Plagens-Rotman K, Piskorz-Szymendera M, Chmaj-Wierzchowska K, Pięta B. Breast cancer - Analysis of the selected risk factors. Eur. J. Gynaecol. Oncol. 2017; 3: 425-430.
Search in Google Scholar Back to article
19. Plagens-Rotman K, Żak E, Pięta B. Odds ratio analysis in women with endometrial cancer. Prz. Menopauz. 2016; 1: 12-19.
Search in Google Scholar Back to article
20. Act of November 6, 2008 on patient rights and the Ombudsman for Patient Rights (consolidated text of the Journal of Laws of 2020, item 849).
Search in Google Scholar Back to article
21. the Code of Medical Ethics (https://nil.org.pl/uploaded_images/1574857770_kodeks-etyki-lekarskiej.pdf, access: 11.06.2020).
Search in Google Scholar Back to article

The occurrence of ovarian cancer in the population of urban and rural women, BRCA1 and BRCA2 genes mutation testing and the general rules on the patient’s consent to treatment

References

Paradigm

My account